…for Lykos, the final rejection mailed on December 19, 2024 is not necessarily the end of the road for its IP pursuits. The company has until the March 19, 2025 deadline (which can be extended for a fee until June 19, 2025) to decide its next steps… As Lykos respresentative said, “This most recent USPTO office action is another step in the application process and a common result at this stage. As is normal practice, we are thoroughly reviewing the examiner’s comments and intend to respond to the office action in the near future. We remain confident in the strength of the application.”

Lykos may elect to file a request for continued examination (RCE), allowing it to once again make amendments or arguments in an attempt to overcome the rejections maintained by the Examiner. Alternatively, Lykos may elect to abandon its US 18/611,564 application in favor of a continuation application with a new set of refined claims, or a continuation-in-part (CIP) that includes new subject matter. Lykos also could choose to appeal the Examiner’s decision to a panel of administrative judges at the Patent Trial and Appeals Board (PTAB)… Lykos could potentially also amend their claims to try to more substantially work around the prior art cited by the Examiner.

Original Article (Psychedelic Alpha):
Patent analysis: Lykos suffers blow from USPTO as all patent claims stand finally rejected
Artwork Fair Use: Public domain